Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...

Bladder cancer ranks as the 10th most commonly diagnosed cancer globally, affecting both men and women. Approximately 75% of patients are initially diagnosed with non-muscle invasive bladder cancer ...

At ESMO 2024, Dr. Andrea Necchi presented the results of an interim analysis of SunRISe-4, noting a pathological complete response rate in the combination arm of 42% and pathologic objective response ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas was host to the Bladder Cancer Course and the session Metastatic Urothelial Cancer. Dr. Vadim S. Koshkin ...

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an ...

Key TakeawaysFirst-ever annual report from the American College of Surgeons National Cancer Database includes in-depth data ...

The deal with Tubulis will help Gilead regain its footing in the ADC space following the withdrawal of Trodelvy in bladder ...

This is frequently diagnosed in dogs that were never spayed and the only type of cancer in dogs that has research showing ...

The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic ...

The TNM staging approach, which stands for tumour, nodes, and metastasis, is the most widely used method for staging prostate ...

Cervical cancer can develop without noticeable symptoms. However, these 8 early signs of cervical cancer may appear as the ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75 ...